315 related articles for article (PubMed ID: 32633320)
21. Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice.
Moritani M; Yoshimoto K; Tashiro F; Hashimoto C; Miyazaki J; Ii S; Kudo E; Iwahana H; Hayashi Y; Sano T
Int Immunol; 1994 Dec; 6(12):1927-36. PubMed ID: 7696210
[TBL] [Abstract][Full Text] [Related]
22. Fas and Fas ligand immunolocalization in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.
Redd S; Ginn S; Ross JM
Histochem J; 2002; 34(1-2):1-12. PubMed ID: 12365794
[TBL] [Abstract][Full Text] [Related]
23. Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD mice.
Han J; Zhong J; Wei W; Wang Y; Huang Y; Yang P; Purohit S; Dong Z; Wang MH; She JX; Gong F; Stern DM; Wang CY
Diabetes; 2008 Aug; 57(8):2118-27. PubMed ID: 18477810
[TBL] [Abstract][Full Text] [Related]
24. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
[TBL] [Abstract][Full Text] [Related]
25. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.
Hancock WW; Polanski M; Zhang J; Blogg N; Weiner HL
Am J Pathol; 1995 Nov; 147(5):1193-9. PubMed ID: 7485382
[TBL] [Abstract][Full Text] [Related]
26. The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes.
Pearson JA; Wong FS; Wen L
J Autoimmun; 2016 Jan; 66():76-88. PubMed ID: 26403950
[TBL] [Abstract][Full Text] [Related]
27. TAK1 inhibition prevents the development of autoimmune diabetes in NOD mice.
Cao H; Lu J; Du J; Xia F; Wei S; Liu X; Liu T; Liu Y; Xiang M
Sci Rep; 2015 Oct; 5():14593. PubMed ID: 26459028
[TBL] [Abstract][Full Text] [Related]
28. PAHSAs attenuate immune responses and promote β cell survival in autoimmune diabetic mice.
Syed I; Rubin de Celis MF; Mohan JF; Moraes-Vieira PM; Vijayakumar A; Nelson AT; Siegel D; Saghatelian A; Mathis D; Kahn BB
J Clin Invest; 2019 Aug; 129(9):3717-3731. PubMed ID: 31380811
[TBL] [Abstract][Full Text] [Related]
29. Dynamic changes in pancreatic endocrine cell abundance, distribution, and function in antigen-induced and spontaneous autoimmune diabetes.
Pechhold K; Zhu X; Harrison VS; Lee J; Chakrabarty S; Koczwara K; Gavrilova O; Harlan DM
Diabetes; 2009 May; 58(5):1175-84. PubMed ID: 19228810
[TBL] [Abstract][Full Text] [Related]
30. Pancreatic islet cell phenotype and endocrine function throughout diabetes development in non-obese diabetic mice.
Kornete M; Beauchemin H; Polychronakos C; Piccirillo CA
Autoimmunity; 2013 Jun; 46(4):259-68. PubMed ID: 23256897
[TBL] [Abstract][Full Text] [Related]
31. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC; Power RF
J Immunol; 1995 May; 154(9):4874-82. PubMed ID: 7722337
[TBL] [Abstract][Full Text] [Related]
32. Cytokines activate caspase-3 in insulinoma cells of diabetes-prone NOD mice directly and via upregulation of Fas.
Augstein P; Bahr J; Wachlin G; Heinke P; Berg S; Salzsieder E; Harrison LC
J Autoimmun; 2004 Dec; 23(4):301-9. PubMed ID: 15571924
[TBL] [Abstract][Full Text] [Related]
33. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells.
Yoon JW; Yoon CS; Lim HW; Huang QQ; Kang Y; Pyun KH; Hirasawa K; Sherwin RS; Jun HS
Science; 1999 May; 284(5417):1183-7. PubMed ID: 10325232
[TBL] [Abstract][Full Text] [Related]
34. [Studies on the pathogenesis of type I diabetes mellitus--destruction of pancreatic beta cells by cytotoxic T lymphocytes in nonobese diabetic mice].
Nagata M
Nihon Naibunpi Gakkai Zasshi; 1990 Mar; 66(3):145-58. PubMed ID: 2189754
[TBL] [Abstract][Full Text] [Related]
35. Progression of spontaneous autoimmune diabetes is associated with a switch in the killing mechanism used by autoreactive CTL.
Qin H; Trudeau JD; Reid GS; Lee IF; Dutz JP; Santamaria P; Verchere CB; Tan R
Int Immunol; 2004 Nov; 16(11):1657-62. PubMed ID: 15466911
[TBL] [Abstract][Full Text] [Related]
36. Temporal relationship between immune cell influx and the expression of inducible nitric oxide synthase, interleukin-4 and interferon-gamma in pancreatic islets of NOD mice following adoptive transfer of diabetic spleen cells.
Reddy S; Karanam M; Krissansen G; Nitschke K; Neve J; Poole CA; Ross JM
Histochem J; 2000 Apr; 32(4):195-206. PubMed ID: 10872884
[TBL] [Abstract][Full Text] [Related]
37. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.
Chosich N; Harrison LC
Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical study of caspase-3-expressing cells within the pancreas of non-obese diabetic mice during cyclophosphamide-accelerated diabetes.
Reddy S; Bradley J; Ginn S; Pathipati P; Ross JM
Histochem Cell Biol; 2003 Jun; 119(6):451-61. PubMed ID: 12802593
[TBL] [Abstract][Full Text] [Related]
39. Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes.
Augstein P; Elefanty AG; Allison J; Harrison LC
Diabetologia; 1998 Nov; 41(11):1381-8. PubMed ID: 9833948
[TBL] [Abstract][Full Text] [Related]
40. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells.
Grewal IS; Grewal KD; Wong FS; Picarella DE; Janeway CA; Flavell RA
J Exp Med; 1996 Nov; 184(5):1963-74. PubMed ID: 8920883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
